Instil Bio Inc (TIL) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Instil Bio Inc   (NASDAQ: TIL)


Instil Bio Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Instil Bio Inc's ROI in the second quarter of 2026?
Instil Bio Inc recorded a cumulative net loss of $-30 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -15%.

Within the Healthcare sector 282 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3299 to 3388.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -18.06 % -18.81 % -19.67 % -18.89 % -18.96 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 194 200 203 211 230
Return On Investment (TTM) -15 % -22.46 % -32.4 % -32.15 % -34.3 %
TIL's Overall Ranking # 3388 # 3299 # 3157 # 3388 # 2890
Seq. Investment Change TTM -4.27 % -4.26 % -5.67 % -5.22 % -5.15 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -30 -47 -71 -75 -85

TIL Company Profile >> Back to TIL Roi Comparisons >> See Annual TIL Return On Investment



Return On Investment TIL's Ranking
Within: No.
Industry # 32
Sector # 283
Overall # 3388

Return On Investment Statistics
High Average Low
-6.02 %
-30.12 %
-49.95 %
(Dec 31 2017)   (Sep 30 2023)



  News about Instil Bio Inc Return on Investment ROI

Instil Bio: Overcoming Financial Challenges and Paving the Way for Cancer Therapies

January 16, 2024


In exciting news in the field of biopharmaceuticals, Instil Bio, Inc. recently released a strategic update, outlining their path forward in developing revolutionary tumor infiltrating lymphocyte (TIL) therapies for patients battling cancer. The company, listed on NASDAQ as TIL, has been dedicated to finding innovative solutions for cancer treatment, but has faced significant financial challenges. A closer examination reveals that Instil Bio recorded a staggering net loss of $-197 million during the 12-month period ending in the third quarter of 2023, resulting in a discouraging negative return on investment (ROI) of -50.3%.
This financial setback undeniably poses a significant hurdle for the company. However, it is important to assess the implications of this situation and understand how it impacts Instil Bio s future prospects.
Firstly, the impressive dedication demonstrated by Instil Bio towards making significant advancements in cancer treatment should not be overshadowed by this temporary hindrance. The company s focus on developing TIL therapies showcases their commitment to tackling the challenges posed by cancer, a disease that affects millions of lives globally.





Financial Statements
Instil Bio Inc's II. Quarter Investments $ 194 Millions TIL's Balance sheet
Instil Bio Inc's II. Quarter Income $ -4 Millions Quarterly TIL's Income Statement
TIL's Income by Division See TIL's Income by Division


TIL Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 199 256 310 449 566
Y / Y Investment Growth -22.29 % -17.63 % -30.92 % -20.64 % 674.95 %
Net Income in Millions -71 -74 -156 -223 -157
Y / Y Net Income Growth - - - - -
Annual Return On Investment -35.92 % -29 % -50.29 % -49.67 % -27.69 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
TIL's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for TIL's Competitors
Subscribers only: Roi for Instil Bio Inc's Suppliers
Subscribers only: Return On Investment for TIL's Customers

Other Ratios
TIL's Roa TIL's Inventory Turnover Ratio TIL's Growth Rates TIL's Dividend Statistics
TIL's Profitability Ratios TIL's Asset Turnover Ratio TIL's Dividend Growth
TIL's Roe TIL's Valuation Ratios TIL's Financial Strength Ratios TIL's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-26T07:39:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.